Patents

US 11903918 B2: Fumarate ester dosage forms with enhanced gastrointestinal tolerability

Granted
2024-02-20
Filed
2021-01-07 application 17143439
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Described herein are pharmaceutical compositions comprising one or more fumarate esters and methods for treating multiple sclerosis subjects with the compositions where the incidence of gastrointestinal side effects is reduced compared to treatments comprising dimethyl fumarate (e.g., TECFIDERA®). In particular, described herein are oral pharmaceutical compositions comprising monomethyl fumarate in a liquid vehicle that have reduced gastrointestinal side effects.

Source: PVGPATDIS, file of 2026-04-10 (ipg240220.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
BANNER LIFE SCIENCES LLC 38 patentsUS company or organizationHigh Point, NCPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Franck RousseauChapel Hill, NC2PVGPATDIS, file of 2026-04-10
Thomas Wallace LateganNew Orleans, LA1PVGPATDIS, file of 2026-04-10
Tiffany Nicole SpragueGreensboro, NC1PVGPATDIS, file of 2026-04-10
Jason M. VaughnMaineville, OH18PVGPATDIS, file of 2026-04-10
Justin R. HugheyAsheboro, NC22PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/22PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/08PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-01-29Assignment
Assignment of assignor's interest
LATEGAN, THOMAS WALLACE signed 2021-01-11
ROUSSEAU, FRANCK S.F. signed 2021-01-11
SPRAGUE, TIFFANY NICOLE signed 2021-01-12
VAUGHN, JASON MICHAEL signed 2021-01-12
HUGHEY, JUSTIN ROY signed 2021-01-20
BANNER LIFE SCIENCES LLC HIGH POINT, NC55181/16ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.